Nationwide Fund Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,992
| Closed | -$4.32M | – | 1368 |
|
|
2017
Q3 | $4.32M | Buy |
11,992
+4,822
| +67% | +$1.74M | 0.02% | 1089 |
|
|
2017
Q2 | $2.1M | Buy |
7,170
+1,658
| +30% | +$486K | 0.01% | 1409 |
|
|
2017
Q1 | $1.94M | Sell |
5,512
-394
| -7% | -$139K | 0.01% | 1411 |
|
|
2016
Q4 | $1.09M | Buy |
5,906
+316
| +6% | +$58.2K | ﹤0.01% | 1725 |
|
|
2016
Q3 | $1.44M | Sell |
5,590
-51
| -0.9% | -$13.1K | 0.01% | 1568 |
|
|
2016
Q2 | $1.2M | Sell |
5,641
-37
| -0.7% | -$7.9K | 0.01% | 1615 |
|
|
2016
Q1 | $1.19M | Sell |
5,678
-93
| -2% | -$19.5K | 0.01% | 1614 |
|
|
2015
Q4 | $1.46M | Buy |
5,771
+119
| +2% | +$30.1K | 0.01% | 1517 |
|
|
2015
Q3 | $929K | Sell |
5,652
-45
| -0.8% | -$7.4K | ﹤0.01% | 1765 |
|
|
2015
Q2 | $1.07M | Sell |
5,697
-1,968
| -26% | -$369K | ﹤0.01% | 1813 |
|
|
2015
Q1 | $1.27M | Sell |
7,665
-201
| -3% | -$33.2K | 0.01% | 1765 |
|
|
2014
Q4 | $1.83M | Buy |
7,866
+78
| +1% | +$18.1K | 0.01% | 1469 |
|
|
2014
Q3 | $1.41M | Buy |
7,788
+7
| +0.1% | +$1.27K | 0.01% | 1640 |
|
|
2014
Q2 | $1.5M | Buy |
7,781
+102
| +1% | +$19.6K | 0.01% | 1651 |
|
|
2014
Q1 | $1.4M | Buy |
7,679
+481
| +7% | +$87.4K | 0.01% | 1571 |
|
|
2013
Q4 | $1.23M | Sell |
7,198
-89
| -1% | -$15.1K | 0.01% | 1758 |
|
|
2013
Q3 | $1.14M | Buy |
7,287
+1,457
| +25% | +$228K | 0.01% | 1777 |
|
|
2013
Q2 | $1.01M | Buy |
+5,830
| New | +$1.01M | 0.01% | 1673 |
|